Astrana Health Inc ASTH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
-
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
-
Astrana Health, Inc. Reports Second Quarter 2026 Results
-
Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call
-
Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth
-
Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year
-
Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate
Trading Information
- Previous Close Price
- $35.57
- Day Range
- $34.71–35.68
- 52-Week Range
- $18.08–51.60
- Bid/Ask
- $34.61 / $40.14
- Shares Outstanding
- 49.60M
- Market Cap
- $1.73B
- Volume/Avg
- 266,857 / 498,761
Key Statistics
- Price/Earnings (Normalized)
- 16.30
- Price/Sales
- 0.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.89%
Company Profile
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company’s three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,000
- Website
- https://www.astranahealth.com
Valuation
|
Metric
|
ASTH
|
|---|---|
Price/Earnings (Normalized) | 16.30 |
Price/Book Value | 2.07 |
Price/Sales | 0.45 |
Price/Cash Flow | 12.03 |
Price/Earnings
ASTH
Financial Strength
|
Metric
|
ASTH
|
|---|---|
Quick Ratio | 1.19 |
Current Ratio | 1.23 |
Interest Coverage | 1.64 |
Quick Ratio
ASTH
Profitability
|
Metric
|
ASTH
|
|---|---|
Return on Assets (Normalized) | 2.94% |
Return on Equity (Normalized) | 7.85% |
Return on Invested Capital (Normalized) | 6.33% |
Return on Assets
ASTH
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|$!r | LOCK|$vR | — | |||
| HCA Healthcare Inc
HCA
| LOCK|l?Z@$v | LOCK|<Y?<f | $92B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|vNxn | $28B | |||
| Tenet Healthcare Corp
THC
| LOCK|w!<Lv> | LOCK|$@<k> | $20B | |||
| Fresenius Medical Care AG
FMCQF
| — | LOCK|H!KW | $12B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|TM$%^@ | LOCK|Rg$H^ | $12B | |||
| Encompass Health Corp
EHC
| — | LOCK|@?cY | $12B | |||
| DaVita Inc
DVA
| LOCK|XB^Knx% | LOCK|x#HT# | $11B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|##KsTsW | LOCK|&n^@y | $10B | |||
| Ensign Group Inc
ENSG
| — | LOCK|mB^@ | $10B |
United States